Major Rating Factors:
Weak profitability (1.4 on a scale of 0 to 10) with operating losses during 2022. Return on equity has been low, averaging -59.2%. Weak overall results on stability tests (0.5) including weak risk adjusted capital in prior years. Fair capitalization for the current period (4.0) based on fair risk adjusted capital (moderate loss scenario) reflecting some improvement over results in 2019.
Other Rating Factors:
Fair quality investment portfolio (3.3). Excellent Liquidity (9.1).
Stability Factors:
C - Past results on our Risk-Adjusted Capital tests.
I - Past results on our Investment Safety Index.
Principal Lines of Business:
Ind health (79.5%), group health (20.5%)
Licensed in:
NY